Stay on top of the latest developments in global IP protection and enforcement.


Pharmaceuticals, biotechnology, diagnostics, healthcare and chemicals operate in a world of uncertainty. Issues around cost and pricing, clinical and operational innovation, customer and consumer engagement and regulatory compliance are spiralling. In addition, new and evolving technology advancements have primed the life sciences sector for disruption. Each year brings changes and challenges which companies must learn to adapt to and thrive in.

Over the last decade the conferences have provided unrivalled expert insight into the latest developments in patents, regulatory and IP law in the global life science industry.

Based on original research with IP practitioners, our Intellectual Property events provide timely practical guidance on every aspect of strategic IP planning and protection including patent prosecution, licensing, infringement litigation, Hatch Waxman litigation, ITC and PTAB proceedings, and more. With each event targeted to specific industries and practice groups, our forums provide high-level insights on the most recent developments while also allowing for essential in-person networking and business development opportunities with your industry colleagues.


Speak to us about an all year round event pass for your company and get some great savings by emailing



Life Sciences IP Summit

Life Sciences IP Summit

October 15 - 16, 2019 The Westin Grand Munich, Munich

This conference sets the scene for the future of SPCs in Europe, providing a deeper understanding of secondary medical use patents and give practical insights on how an in-house counsel should manage patent litigation from beginning to end. This event will provide you with comprehensive knowledge and benchmarking opportunities to ensure you are leading the way in patent protection. More

Pharma & Biotech Patent Litigation

Pharma & Biotech Patent Litigation

February 25 - 26, 2020 Amsterdam

This is your once-a-year opportunity to brainstorm and network with General Counsel and Head of IP from leading Pharmaceutical and Biotech companies. Receive vital updates and in-depth analysis that you can use to implement an effective patent litigation strategy. More